Category Specific RSS

Tony Farnham

Tony Farnham is a financial markets veteran and Analyst/Financial Writer at The Capital Network.

Carly Holdings’ EV Trial targets aspiring EV buyers

Most consumers love ‘try before you buy’ opportunities, especially when the goods or services involved are big ticket items laden…

2 years ago

Careteq further penetrates its large and growing addressable market

Addressing industry thematics of cloud-based computing and technology disruption and the rapid aging of Western populations, Careteq (ASX:CTQ ) has…

3 years ago

Proteomics’ PromarkerD test enters the lucrative US market

Successful early diagnosis of diabetic kidney disease (DKD) delivers a win-win-win situation for the medical professionals who treat this disease,…

3 years ago

4DMedical’s tech platform now unambiguously in early commercialisation

Back in the 1970s the world marvelled as the then revolutionary CT scan and nuclear medicine technologies that allowed health…

3 years ago

Proteomics’ early detection test for endometriosis potentially a game changer

Endometriosis is a chronic disease where tissue similar to the lining of the uterus grows outside the uterus. Women are…

3 years ago

IRIS Metals gains $3.5 million funding for US lithium

IRIS Metals (ASX: IR1) announced an investment of $1,500,000 from the Electrification and Decarbonization AIE LP Fund, managed by Waratah…

4 years ago